ABSTRACT Elucidating cytosine modification differences between human populations can enhance our understanding of ethnic specificity in complex traits. In this study, cytosine modification levels in 133 HapMap lymphoblastoid cell lines derived from individuals of European or African ancestry were profiled using the Illumina HumanMethylation450 BeadChip. Approximately 13% of the analyzed CpG sites showed differential modification between the two populations at a false discovery rate of 1%. The CpG sites with greater modification levels in European descent were enriched in the proximal regulatory regions, while those greater in African descent were biased toward gene bodies. More than half of the detected population-specific cytosine modifications could be explained primarily by local genetic variation. In addition, a substantial proportion of local modification quantitative trait loci exhibited population-specific effects, suggesting that genetic epistasis and/or genotype · environment interactions could be common. Distinct correlations were observed between gene expression levels and cytosine modifications in proximal regions and gene bodies, suggesting epigenetic regulation of interindividual expression variation. Furthermore, quantitative trait loci associated with population-specific modifications can be colocalized with expression quantitative trait loci and single nucleotide polymorphisms previously identified for complex traits with known racial disparities. Our findings revealed abundant population-specific cytosine modifications and the underlying genetic basis, as well as the relatively independent contribution of genetic and epigenetic variations to population differences in gene expression.
D
NA methylation is a covalent cytosine modification that occurs at the C-5 position of cytosines at CpG dinucleotides and is dispersed unevenly over the genome (Bird 2002) . Interindividual variation in cytosine modifications can be affected by both the stable underlying genetic sequence and dynamic environmental influences (Flanagan et al. 2006; Bock et al. 2008) . Cytosine modifications are known to play an important role in the regulation of gene expression, with promoter methylation acting to silence gene expression (Grewal and Moazed 2003) . Previous studies of human variation in gene expression have shown that differential gene expression can influence a variety of complex traits, including susceptibilities to common diseases and variation in drug response (Schadt et al. 2005; Emilsson et al. 2008; Cookson et al. 2009 ).
The lymphoblastoid cell lines (LCLs) from the International HapMap Project (HapMap 2003; HapMap 2005) have been used recently for investigating within-and betweenpopulation differences in promoter methylation (Bell et al. 2011; Fraser et al. 2012) . Furthermore, previous work from our group and others has demonstrated that common genetic variants and microRNAs contributed to the variation in gene expression between LCLs derived from individuals of Yoruba people from Ibadan, Nigeria (YRI) and Caucasian residents of European ancestry from Utah (CEU) (Stranger et al. 2007; Zhang et al. 2008a; Huang et al. 2011) . Due to tissue-specific DNA methylation patterns (Rakyan et al. 2008) , studies in LCLs have the distinct advantage of being a pure population of B cells, as primary samples from humans can include more than one cell type, which may confound downstream analyses.
We reasoned that an evaluation of the natural variation in cytosine modifications at single-base resolution beyond the promoter regions could help elucidate the epigenetic contribution to interpopulation gene expression differences as well as other phenotypic differences, such as risks for common diseases and drug response variation. Furthermore, an improved understanding of the genetic basis of cytosine modification variation and the relationships between modification quantitative trait loci (mQTL) and expression quantitative trait loci (eQTL) would provide novel insights into the genetic architectures of gene expression and other complex traits.
Specifically, we collected genome-wide cytosine modification data on more than 480,000 CpG sites using the Illumina Infinium HumanMethylation450 BeadChip (450K array) (Bibikova et al. 2011 ) in a collection of 60 unrelated CEU and 73 unrelated YRI samples, for which comprehensive genotypes of single nucleotide polymorphisms (SNPs) (Frazer et al. 2007) and gene expression (Zhang et al. 2008a ) data are available. Technically, the 450K array requires bisulfite-converted DNA to distinguish modified from unmodified cytosines. Although 5-methylcytosine (5-mC) is the most common covalent cytosine modification in the human genome, 5-mC can be oxidized by the ten-eleven translocation (TET) enzymes to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine, and 5-carboxylcytosine (Tahiliani et al. 2009; Ito et al. 2011) . Because bisulfite conversion cannot distinguish between 5-mC and 5-hmC Jin et al. 2010) , we have chosen to use the term "cytosine modification" to avoid any implied bias. In this study, we identified the differentially modified cytosines between the CEU and YRI samples, assessed the genetic contribution to these differences, and investigated the implications of mQTL on gene expression and other complex traits with known racial disparities.
Materials and Methods

Sample preparation and cytosine modification profiling
We purchased 50 mg of genomic DNA for 60 unrelated CEU and 74 unrelated YRI (59 phase 1/2 and 15 phase 3 samples) from the Coriell Institute for Medical Research (Camden, NJ). To confirm the cell line identities, we genotyped 47 SNPs from the Sequenom iPLEX Sample ID Plus Panel (Sequenom, San Diego, CA) and compared them with the HapMap data (release 28) for 24 randomly selected samples. As an internal control, we selected 10 LCLs (4 CEU and 6 YRI samples), previously pelleted by the Pharmacogenetics of Anticancer Agents Research (PAAR) Group Cell Core at the University of Chicago, for DNA isolation and array profiling. DNA was isolated using Qiagen Gentra Puregene Core Kit B (Qiagen, Germantown, MD).
The University of Chicago Genomics Core Facility was provided with 800 ng of DNA for bisulfite conversion with the Zymo EZ cytosine modification kit (Zymo Research, Irvine, CA). Cytosine modification levels were profiled using the Illumina 450K array (Illumina, San Diego, CA), according to the manufacturer's protocol. The efficacy of the bisulfite conversion was checked by PCR amplification and DNA sequencing of selected genomic regions. Approximately 150 ng of bisulfite-converted DNA from each sample was used for array hybridization. To limit the potential bias due to experimental batches, samples were randomized by population identity and hybridized in three batches.
Relative Epstein-Barr virus copy numbers
Quantitative real-time PCR (qRT-PCR) was performed to determine relative baseline Epstein-Barr virus (EBV) copy numbers in the DNA samples using a TaqMan assay, which interrogated a 66-bp fragment at the DNA polymerase locus. A 90-bp assay from the NRF1 locus (encoding nuclear respiratory factor 1) was used as an internal reference (Supporting Information, Table S1 ). Genomic DNA template (0.5 ng) and Gene Expression master mix was used for each TaqMan reaction performed according to the manufacturer's protocol (Applied Biosystem, Foster City, CA). A standard curve method was implemented using quantities of total genomic DNA obtained from the IB4 cell line (gift from Janet Rowley's Laboratory, University of Chicago), which was run as a reference line on each plate for calculating the relative EBV copy numbers (Table S2) . Any samples that did not achieve ,20% standard deviation (in triplicates) were dropped from the analysis.
Cytosine modification data processing
To remove probes that potentially cross-hybridize, we aligned 482,421 probe sequences to the human genome (hg19) . Both forward and reverse strands of the genome reference were bisulfite converted in silico, in which all cytosines within CpGs were converted to N's and all remaining C's to T's. All cytosines within CpG sites in the probe sequences were converted to N's. Probe sequences were aligned to the converted genome reference using Bowtie2 (v2.0.0 beta5) (Langmead and Salzberg 2012) in an end-to-end exhaustive alignment mode, with seed size of 16 bases, interval between seeds of 12 bases, allowing one mismatch in seeds. The scoring parameters were set so that the alignment allowing #4 ambiguous bases (i.e., N's) and #2 mismatches in total. The alignment resulted in 340,658 perfectly matching unique probes (File S1). We further removed probes containing common SNPs within 20 bp of the interrogated CpG sites that had minor allele frequency (MAF) .0.01 from dbSNP v135 (Sherry et al. 2001) (Table S3) .
Cytosine modification levels were summarized with the Illumina GenomeStudio-Modification Module v1.9 (GenomeStudio). The b-value was calculated as the proportion of modified probe intensity over the sum of both modified and unmodified probe intensities; the M-value was calculated as the log 2 ratio of the intensities of modified probe vs. unmodified probe. We detected and removed NA18862, which contained .5% of failed CpG probes with detection P.0.01 (Fernandez et al. 2012) . CpG probes with detection P.0.01 in $5% samples were also removed. Background correction (Borevitz et al. 2003) and quantile normalization (Bolstad et al. 2003) were then performed on the M-values or b-values of the remaining 290,577 probes across all samples. COMBAT (Johnson et al. 2007) was used to correct the batch effects of array hybridization.
Comparison of the b-values between 10 DNA samples obtained from the Coriell Institute and 10 internal controls indicated a stronger correlation between sample pairs from the two sources than between random pairs of samples (r 2 intraquantile range: 0.94-0.98 vs. 0.80-0.86), confirming the stability of cytosine modification profiles.
Genic distributions of cytosine modifications
To examine the genic distributions of cytosine modifications within populations, population-specific CpGs, and CpGs correlated with gene expression, we aligned transcription start sites (TSSs) and end sites (TESs) across 18,036 genes. Regions 10 kb upstream of TSSs and 10 kb downstream of TESs were binned by 500 bp. Gene bodies were divided into 10 quantiles by length. Gene regions were therefore defined as regions covering 10 kb upstream of TSSs, 59-UTRs (untranslated regions), gene bodies, 39-UTRs, and 10 kb downstream of TESs.
Identification of differentially modified cytosines between populations
The final analysis set was composed of 283,540 autosomal CpG probes in 60 CEU and 73 YRI samples. Since the M-value was shown to provide better detection sensitivity at extreme modification levels (Du et al. 2010) , we used the M-value in the statistical comparisons unless otherwise mentioned. A linear model: cytosine modification level population + gender + error, was used to identify differentially modified cytosines. False discovery rate (FDR) was estimated by 100 permutations across samples using an approximate test (Anderson and Robinson 2002) . The results obtained by linear regression were strongly correlated with results obtained by the nonparametric Wilcoxon rank-sum test (Spearman's r = 0.92 across probe P-values). We further evaluated potential confounders including intrinsic growth rate (Im et al. 2012) and EBV copy number (Table  S2) for their effects on the differential cytosines using multivariate linear regression models.
Genetic association of cytosine modification variation SNP genotypes were obtained from the International HapMap Project (release 28). For SNP association tests within each population, SNPs that were called in at least 48 CEU samples or 48 YRI samples with MAF .0.05 and that were not significantly deviated from the Hardy-Weinberg equilibrium (HWE) (P.0.0001) were selected. Cytosine modification levels of the 36,597 differential CpG sites detected at FDR ,1% were regressed on SNP allelic dosage using an additive model, with gender as a covariate. FDR was estimated by 100 permutations. For the local scan of SNPs within 6100 kb of the target CpG sites, in total 1,530,751 SNPs and 36,577 CpG sites (6,227,494 associations) were tested in the CEU samples, resulting in 28,299 significant associations at 5% FDR. In the YRI samples, in total 1,696,808 SNPs and 36,577 CpG sites (6,843,483 associations) were tested, resulting in 19,701 significant associations. F st values, a measure of population differentiation, were calculated for SNPs in dbSNP v135 (Sherry et al. 2001 ) with allele frequencies obtained from the unrelated individuals in the complete collection of CEU and YRI samples.
For SNP association tests across populations, SNPs that had genotypes in at least 96 samples with MAF .0.05 across populations and that were not significantly deviated from the HWE (P.0.0001) in either the CEU or YRI samples were selected. This resulted in 1,766,136 SNPs and 36,580 CpG sites, totaling 7,136,801 tests. Cytosine modification levels were then regressed on SNP allelic dosage using an additive model, with gender as a covariate. FDR was estimated by 100 permutations. For each significant association, Pearson's correlation r 2 with modification level was estimated for both SNP effect and population identity.
Correlation analysis of cytosine modification and gene expression
Gene expression data were previously generated by our group using the Affymetrix Human Exon 1.0ST Array (exon array) (Zhang et al. 2008a ). To avoid sample mix-ups (Westra et al. 2011) , we genotyped 47 SNPs from the Sequenom iPLEX Sample ID Plus Panel in 106 random samples previously profiled for gene expression and maintained at the PAAR group. All sample identities were confirmed by comparing the genotype calls with the HapMap data (release 28). The exon array data were background corrected (Borevitz et al. 2003) and quantile normalized (Bolstad et al. 2003) across 176 CEU and YRI samples (in parents-child trios) after removing probes containing common SNPs (MAF.0.01) based on dbSNP v135 (Sherry et al. 2001) . In total, 14,669 transcript clusters (gene level) mapped to unique Entrez Gene IDs were evaluated for correlation between gene expression and the Mvalues of 208,808 CpG sites located within gene regions, corresponding to 269,316 CpG-gene pairs. Correlation analyses were carried out across 58 CEU and 57 YRI samples that had both expression and modification data, as well as within each population, using a linear model: gene expression cytosine modification + error. FDR was estimated by 100 permutations.
Result validation
We performed bisulfite sequencing within four loci, LIPH (encoding lipase member H), TBX21 (encoding T-box 21), DENND2D (encoding DENN/MADD domain containing 2D), and CR2 (encoding complement component receptor 2), that were found to be differentially modified and expressed between the two populations. Bisulfite sequencing at these loci was performed on at least 20 random samples from the original DNA collection used in the 450K array profiling. ZymoTaq polymerase and bisulfite primers (Table S4) were used to amplify 200 bp fragments that included the CpG sites interrogated by the 450K array as well as adjacent CpGs.
RT-PCR was performed to measure the expression levels of TBX21, DENND2D, LIPH, and CR2. Total RNA was extracted from 5 million cells using Qiagen RNeasy Plus Mini kit following the manufacturer's protocol. mRNA was reverse transcribed to cDNA using Applied Biosystems High-Capacity Reverse Transcription kit. qRT-PCR was performed for each gene, and huB2M [beta-2-microglobulin (NM_004048.2)] was included as an endogenous control using TaqMan Gene Expression Assays. The TaqMan primers and probes (DENND2D, Hs00227687_m1; TBX21, Hs00203436_m1; LIPH, Hs00975887_m1; and CR2, Hs01079096_m1) were labeled with a FAM reporter dye and MGB quencher dye. The huB2M primer/probe mixture was labeled with VIC reporter dye and MGB quencher dye. The fast thermocycler parameters were: 95°for 20 sec and 40 cycles of 95°for 1 sec and then 60°for 20 sec, with ramping speeds of 1.6°-1.9°/sec. Each sample was run on a minimum of two plates in triplicate on each plate with standard deviation #15%.
Results
Variation of cytosine modifications within populations
We profiled cytosine modification levels on the Illumina 450K array for 60 CEU and 73 YRI samples (HapMap 2003; HapMap 2005) . A total of 283,540 autosomal CpG sites were selected for further analyses (Table S3 ). In general, cytosine modification levels showed a bimodal distribution, representing hyper-and hypomodification ( Figure S1 ). About 82% of the analyzed CpG sites fell within gene regions. Cytosine modification levels were greater in gene bodies than in proximal regulatory regions ( Figure 1A ). In contrast, the variability of cytosine modifications was greater around the proximal regulatory regions than in the gene bodies ( Figure 1B) . To assess the extent of co-modification between CpG sites, we estimated Spearman's r for all CpG pairs ,5 kb apart. As expected, co-modification decreased with distance ( Figure  1C ). Beyond 1 kb, co-modification between CpG sites decreased to about the background level, indicating a much shorter linkage range than genetic variations. CpG pairs that fell within gene bodies exhibited consistently stronger co-modification than those located in other regions. Overall, the CEU and YRI samples showed a similar co-modification pattern ( Figure S2 ).
Population differences in cytosine modifications
Across the CEU and YRI samples, population identity was a prominent variable of cytosine modifications by the principal components analysis (PCA) ( Figure S3 ). We regressed modification levels on population identity for each CpG site, with gender as a covariate. A total of 36,597 (13%) differential CpG sites were detected at nominal P,0.001, corresponding to FDR of 1% (Table S5 ). These sites were not biased to potential genetic hybridization differences between populations. Particularly, probes containing rare SNPs within 20 bp of the interrogated CpG sites were not overrepresented (13.4% among rare SNP-containing probes vs. 12.9% among all analyzed probes), nor were probes overlapping with known copy number variants (CNVs) (Redon et al. 2006 ) (13.3% among probes overlapping CNV regions vs. 12.9% among all analyzed probes).
We examined two confounding factors for the LCLs, the EBV copy number (Table S2) , and the intrinsic growth rate Across the CEU samples, Spearman's r was calculated for all CpG pairs ,5 kb apart. The CpG pairs were then grouped by their relative distance and according to whether both cytosines fell in specific gene regions. The median (bar) and intraquantile range (line) of the signed r 2 across the CpG pairs are plotted against the distance, for 10 kb upstream of TSSs (upstream), 59-UTRs (UTR5), gene bodies, 39-UTRs (UTR3), and 10 kb downstream of TESs (downstream). (Im et al. 2012) . With these covariates being accounted for, population identity remained as the most significant variable for the differential CpG sites ( Figure S4 ), suggesting that the observed population differences were not likely due to these confounding factors. We also compared our data with a published dataset that profiled cytosine modifications for the CEU and YRI samples using the Illumina 27K array (Fraser et al. 2012) . Focusing on the same set of CpG sites and samples, the regression coefficients of between-population differences from the two studies were strongly correlated (r 2 = 0.72) (Figure S5 ), demonstrating that the observed population differences were robust against technical variations across experiments and profiling platforms.
Since the LCLs of the CEU samples have been in culture for a longer time than the YRI samples, we tested whether this confounded the observed population differences. We pooled our 450K array data with cytosine modification profiles of whole blood primary samples from healthy individuals of Dutch descent that were studied on the same platform or the Illumina 27K array (Horvath et al. 2012) . Applying PCA, we found that the primary variations across the CEU, YRI, and Dutch samples were consistent with the gradient of population identity rather than the gradient of cell type or cell culturing time. Our differential CpG sites further separated the CEU, YRI, and Dutch samples along the primary gradient ( Figure S6 ).
Distinct genic distributions of population-specific cytosine modifications
Among the 36,597 differential CpG sites, 27,051 fell within the gene regions of 12,485 genes. The average proportion of differential CpG sites was greater in gene bodies and UTRs than in the 610-kb flanking regions (Figure 2A) . Notably, CpG sites with greater modification levels in the CEU samples (CEU . YRI) were enriched in the regions from 1 kb upstream of TSS to the first gene body quantile (average proportion: 7.5%), but relatively depleted in the regions from the second gene body quantile to the 39-UTR (average proportion: 3.9%). In contrast, CpG sites with greater modification levels in the YRI samples (YRI . CEU) were enriched in the regions from the second gene quantile to the 39-UTR (average proportion: 8.6%), relative to the flanking regions (average proportion: 3.9%). An example was shown for gene STK39 (encoding serine threonine kinase 39), which contained several CEU . YRI sites in the promoter region and YRI . CEU sites in its gene body ( Figure 2B) .
To characterize the differential CpG sites with respect to other chromatin marks, we mapped these populationspecific CpG sites to DNase I hypersensitivity and histone modification peaks derived using a CEU sample (NA12878) from the ENCODE (Encyclopedia of DNA Elements) Project (Dunham et al. 2012) . A substantial proportion of the CEU . YRI sites (44-66%) overlapped with histone modification peaks that mark active regulatory elements and transcription/elongation. The proportion of the YRI . CEU sites that coincided with these histone modifications was markedly lower, between 2 and 6% ( Figure 2C ). In contrast, the YRI . CEU sites were more frequently mapped to peak regions of H3K27me3 (60 vs. 39%), a histone modification that marks repressive domains and silent developmental genes.
Genetic regulation of population differences in cytosine modifications
The observed population differences in cytosine modifications can be caused by both genetic and environmental factors. To assess the genetic contribution, we tested SNP association with cytosine modification levels for the 36,597 differential CpG sites. Within each population, cytosine modification levels were regressed on SNP allelic dosage, with gender as a covariate. Because of strong enrichment of mQTL within the 6100 kb of target CpG sites ( Figure S7 ), we focused on these regions for greater detection power. At 5% FDR, significant modification-SNP associations were (Table S6 ). The median r 2 of associations was 0.31 and 0.30 in the CEU and YRI samples, respectively. The number of associations showed an inverse relationship with the distance between mQTL and their target CpG sites, consistent with a cis-acting mode ( Figure 3A) . In contrast, the strength of associations was less dependent on the distance in general ( Figure 3A) .
Comparison of the association r 2 values between the two populations indicated extensive population specificity of mQTL effects. For modification-SNP associations that were significant in either population and that had fairly common SNP allele frequency (MAF.0.1), the correlation of SNP association r 2 values between the two populations was very low (Pearson's correlation coefficient = 20.03) (Figure S8 ), suggesting that genetic epistasis and/or genotype · environment interactions could be common. An example of common mQTL was shown for a CpG site within gene NRP1 (encoding neuropilin 1) ( Figure 3B ), and population-specific mQTL for a CpG site within gene ANAPC2 (encoding anaphase-promoting complex subunit 2) ( Figure 3C) .
A total of 5237 modification-SNP associations for 497 CpG sites were detected in both populations. As expected, these shared mQTL were enriched in SNPs with high F st values, demonstrating the genetic contribution to the observed population differences in cytosine modifications (Figure S9) . It also implied that at a given differential CpG site, the statistical power in detecting mQTL was likely different between the two populations. To estimate the proportion of differential CpG sites under genetic control, we regressed modification levels on SNP allelic dosage across populations, with gender as a covariate. Here population identity was left out from the regression model, given that for mQTL underlying differential CpG sites, population identity will more or less correlate with genetic variation. At 5% FDR, local SNP associations were detected for 96% of differential CpG sites. We then assessed the relative significance of genetic effect vs. population identity for these associations by comparing their correlation r 2 with modification levels. For 19,651 differential CpG sites (54%), the r 2 of modification levels with at least one mQTL was greater than that with population identity, suggesting a primary genetic contribution.
The role of mQTL in complex traits
We hypothesized that mQTL that underlie differentially modified cytosines between CEU and YRI might have implications on complex traits with known racial disparities. We obtained the top complex-trait associated SNPs in the National Human Genome Research Institute (NHGRI) genome-wide association studies (GWAS) catalog (Hindorff et al. 2009 ) and compared them to the mQTL we identified in both CEU and YRI (Table S6) . A number of mQTL were associated with complex traits with racial disparities (Table  1) , including several metabolic disorders, cardiovascular diseases, autoimmune disorders, and neurological disorders. For instance, five SNPs associated with cholesterol levels and cardiovascular diseases were annotated as an mQTL for a CpG in the promoter region of APOA5 (encoding apolipoprotein A-V), which plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease (Cullen 2000) . All five SNPs showed a higher risk allele frequency in the YRI samples, which had greater levels of cytosine modification of the associated CpG (Figure 4) . These results suggest that mQTL data generated from the LCL model could be used to functionally annotate complex trait-associated SNPs identified in previous GWAS, thus enhancing our understanding of the biological implications of these associations.
Correlation between cytosine modification and gene expression
We evaluated the correlation of cytosine modification levels with gene expression levels measured using the exon array (Zhang et al. 2008a) , across 115 CEU and YRI samples. We examined all CpG-gene pairs for 208,808 CpG sites that were mapped to the gene regions of 14,669 genes. At 5% FDR, 5328 CpG-gene correlated pairs were detected for 13% of the analyzed genes. Positive correlations (3526) were enriched within the regions from the second gene body quantile to the 39-UTR, while negative correlations (1802) peaked in the regions from 500 bp upstream of TSS to the first gene body quantile ( Figure 5A ). Overall, the gene body/UTRs had a greater proportion of correlated CpG sites (3.1%) than upstream (0.87%) and downstream (0.65%) flanking regions.
Cytosine modification levels at 561 differential CpG sites between the CEU and YRI samples correlated with expression levels of 317 differential genes (10% of 3140 differentially expressed genes) (Table S7 ). Technical validation of the cytosine modification and gene expression levels for four such genes (LIPH, TBX21, DENND2D, and CR2) was performed by bisulfite sequencing and qRT-PCR ( Figure S10 ). We found that in some cases adjacent CpGs captured by bisulfite sequencing were even more differentially modified between populations than the CpG measured by the 450K array ( Figure S11 ). Examples of CpG-gene correlations were shown for gene PLA2G4C (encoding phospholipase A2 group IV C), for which CEU showed greater levels of modification for a CpG in the promoter region ( Figure 5B ) and lower levels of modification for a CpG in the gene body ( Figure 5C ). These modification patterns correlated with lower levels of PLA2G4C expression in the CEU samples.
To assess the genetic basis of CpG-gene correlations, we sought to detect modification-expression quantitative trait APOA5, apolipoprotein A-V; C6orf10, chromosome 6 open reading frame 10; CEP72, centrosomal protein 72 kDa; GAB2, GRB2-associated binding protein 2; GABARAPL3, GABA(A) receptors associated protein like 3, pseudogene; HLA-DPA1 -major histocompatibility complex, class II, DP alpha 1; HLA-DPB1, major histocompatibility complex, class II, DP beta 1; HSPB7, heat shock 27-kDa protein family, member 7; PTRF, polymerase I and transcript release factor; RAB7L1-RAB7, member RAS oncogene family-like 1; SAFB2, scaffold attachment factor B2; and TMEM57, transmembrane protein 57.
loci (m-eQTL), which are SNPs contributing to both cytosine modification and gene expression variations. We focused on the CpG-gene correlated pairs for which modification and expression differed between populations. Across 115 CEU and YRI samples, we tested local SNP associations for the 561 differential CpG sites and 317 paired differential genes. Modification or expression levels were regressed on SNP allelic dosage, with population identity and gender as covariates. At 5% FDR, we detected 440 m-eQTL that were associated with 54 CpG sites and 24 genes (Table S8) . For example, the T allele of m-eQTL rs10779587 was associated with a lower expression level of FLVCR1 (encoding feline leukemia virus subgroup C cellular receptor 1) ( Figure 5D ) and greater cytosine modification level of cg01313622 (Figure 5E ). The frequency of this T allele was higher in the CEU samples, consistent with the greater modification level of cg01313622 and lower FLVCR1 expression in the CEU samples.
Discussion
In this study we detected abundant cytosine modification differences between the CEU and YRI samples. More than half of these differential CpG sites could be explained primarily by genetic variation through local mQTL, while population specificity of mQTL effects was also common. We found distinct correlations between gene expression and cytosine modification levels in proximal regions and gene bodies. Furthermore, mQTL underlying population-specific cytosine modifications can be colocalized with eQTL and GWAS SNPs for traits with racial disparities. Based on several considerations, we concluded that the cytosine modification differences observed between the CEU and YRI samples in this study largely reflected true population variations rather than LCL cell culture or other experimental artifacts: (1) Our samples were randomized by population identity across batches, which eliminated confounding due to experimental batch effects. (2) The intrinsic growth rate and EBV copy number were unlikely to bias our results. (3) The consistency between this study with previous work using the Illumina 27K array on populationspecific CpGs (Fraser et al. 2012 ) and mQTL associations (Table S9 ) (Bell et al. 2011; Fraser et al. 2012) demonstrated the robustness of these results across experiments and profiling platforms. (4) PCA of our cytosine modification data and a Dutch whole blood dataset (Horvath et al. 2012 ) demonstrated that cell type or cell line culturing time were not the primary variables. (5) Approximately 54% of the differential CpG sites could be explained primarily by local genetic variation, which was unlikely to be confounded by any biases due to cell culture. (6) mQTL of differential CpG sites underlie several complex traits with known racial disparities between European and African descents.
Considering the overall similar genetic background but different environmental exposures of the two populations, we would expect a substantial proportion of differential modifications attributable to environmental effects, if such effects have been stably maintained in cell cultures. For example, it is unclear whether environment could partially explain the distinct genic enrichment patterns between CpG sites with greater modification levels in the CEU and those greater in the YRI samples. Since the variability of cytosine modifications was comparable between the two populations, our observed population specificity of mQTL effects suggested that genetic epistasis and/or genotype · environment interactions could be common. This is consistent with the findings from a recent study (Fraser et al. 2012) . To dissect the genetic, environment, and interaction effects contributing to the population differences in cytosine modifications, carefully designed experiments that provide population and environment contrasts will be needed.
Transcriptional abundance has been related to cytosine modification in promoter regions and in gene bodies (Ball et al. 2009; Rauch et al. 2009; Bell et al. 2011) . Our study further revealed interindividual correlations of gene expression with cytosine modification levels within these regions. A similar trend has been observed in Arabidopsis (Zhang et al. 2008b) . Cytosine modification within proximal regions could interfere with the transcription initiation (Comb and Goodman 1990) , which was also suggested by the very low modification levels in these regions. However, the interindividual variability of modification levels in these regions was relatively high, suggesting their importance in gene regulation ( Figure 1B) . Genic cytosine modifications were thought to prevent transcription from intragenic cryptic promoters (Zilberman et al. 2007) . The greater levels of cytosine modification and the stronger co-modification within gene bodies further supported this model. Despite the relatively low variability of cytosine modification levels at individual CpG sites in gene bodies ( Figure 1B) , the cumulative effects of these modifications in a gene could be strong.
Investigation of the population differences in cytosine modifications may help elucidate molecular mechanisms of known health disparities. For example, genetic variants of TBX21 have been implicated in childhood asthma, which disproportionally affects African American and Latino children compared with their Caucasian counterparts (Szefler 2010) . We found that this gene had different cytosine modification and gene expression levels between the CEU and YRI samples, suggesting that epigenetic variation could be an additional regulatory component for TBX21. As demonstrated in this study (Table 1) , the mQTL data could provide novel functional annotations to the SNPs previously discovered in GWAS. Considering the lack of data on minority populations in publicly available databases (Hindorff et al. 2009 ), the HapMap LCLs, which were derived from major global populations, would provide a useful resource for annotating the genomes of individuals of non-European descent.
Finally, it is important to note that because the current profiling platforms including the Illumina 450K and 27K arrays require bisulfite-treated DNA, they cannot distinguish between 5-mC and 5-hmC. A recent study demonstrated that the proportion of 5-hmC to 5-mC along the gene bodies was most predictive of gene expression levels in neurons (Mellen et al. 2012) . Thus, future work utilizing base-pair resolution techniques for these two types of modifications will be needed to define the extent to which 5-mC vs. 5-hmC are involved in population-specific cytosine modifications. 
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